Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,131 | Dovepress* | 9,414+ | 1,470 | 10,884 | |
PubMed Central* | 717 | 253 | 970 | ||
Totals | 10,131 | 1,723 | 11,854 | ||
*Since 10 April 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar